Positive Response to Registering Clinical Trials Seen (India)
This article was originally published in PharmAsia News
Executive Summary
India's medical research community has embraced the public registration of clinical trials, reports the latest issue of the British Medical Journal, and public registration today is the norm in India's clinical trial industry. Two years ago the International Committee of Medical Journal Editors (ICMJE) declared that only registered clinical trials would be considered as a reputable basis of published scientific articles. In response, registered worldwide clinical trials with the main U.S. database rose from 13,153 in 2005 to around 40,000 today. India-based researchers today have 467 clinical trials registered with the U.S. clinical trial registry. India's Council of Medical Research (ICMR) is working to create an India-specific national clinical trial registry. ICMR official Dr. Vasantha Muthuswamy says, "We are almost ready to launch the registry. It is undergoing a trial run." (Click here for more
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.